MACLEAN MICHAEL F (Chief Financial Officer) sold 7.1% of their position (4.54K shares) of AVIDITY BIOSCIENCES, INC. on the open market
Open‑market sale worth $329.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/23/2026ACC: 0001599901-26-000023
Officer· Chief Financial Officer
Since Jun 2020
-4.54K
Net shares
Net seller
$329.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4.54K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.81K
Price / share
$72.45
Trade value
$130.92K
% of position
2.8%
1/21/2026
63.83K→62.02K
Common Stock
Direct
Shares
−2.73K
Price / share
$72.45
Trade value
$198.15K
% of position
4.4%
1/21/2026
62.02K→59.29K
Total
Net shares
−4.54K
Net value
-$329.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | S · Sale | −1.81K | $72.45 | $130.92K | 2.8% | 63.83K | 62.02K |
| Common Stock Direct | 1/21/2026 | S · Sale | −2.73K | $72.45 | $198.15K | 4.4% | 62.02K | 59.29K |
| Total | −4.54K | -$329.07K | ||||||
Derivative Transactions0
No derivative transactions reported